Robert Graham Center, Washington, District of Columbia.
American Board of Family Medicine, Lexington, Kentucky.
Am J Prev Med. 2019 Dec;57(6 Suppl 1):S82-S88. doi: 10.1016/j.amepre.2019.07.011.
The U.S. lags behind other developed countries in the use of indices and novel reimbursement models to adjust for social determinants of health (SDH) in medicine. This may be due in part to the inadequate body of research regarding outcomes after implementation of healthcare payments designed to address SDH. This perspective article focuses on four models employed both internationally and domestically to outline the implementation, successes, limitations, and research needed to support national application of SDH models. A brief history of prior models is introduced as a primer to the current U.S. system. Internationally, the United Kingdom and New Zealand employ small area indices to adjust healthcare dollar allocation based on increased social need in an area. Despite published evidence of disparate health outcomes based on SDH, research is limited on the association of SDH indices, subsequent increased reimbursement, and improved healthcare equity. In the U.S., the Massachusetts Managed Care Organization assesses and addresses social needs within communities served by Medicaid. Unsurprisingly, there is evidence of overlap between those with worse health outcomes and those with high social need. However, implementation in Massachusetts is too recent to demonstrate reduced healthcare disparities. Within Minnesota, Hennepin Healthcare System initiated a novel Medicaid waiver that provides extended services to high-need patients under a partial capitation reimbursement program. These services, including increased access to primary care, have promising results in financial improvement of the system, but have not yet demonstrated patient-oriented outcomes. The association between high social risk and poor medical outcomes has been established globally; however, healthcare payment policies designed to respond to this relationship generally lack evidence of affecting outcomes. U.S. policymakers are demonstrating increasing interest in requiring capture of SDH in health care, creating accountability for addressing SDH, paying differentially for patients with increased social risk, or all three. In countries with a legacy of adjusting healthcare payments for social risk, more robust evaluation of associated effects could be helpful. Payers, states, or health systems making similar resource commitments should build in robust longitudinal evaluations of outcomes to inform evolution of their payment policies. SUPPLEMENT INFORMATION: This article is part of a supplement entitled Identifying and Intervening on Social Needs in Clinical Settings: Evidence and Evidence Gaps, which is sponsored by the Agency for Healthcare Research and Quality of the U.S. Department of Health and Human Services, Kaiser Permanente, and the Robert Wood Johnson Foundation.
美国在使用指数和新型报销模式来调整医学中的健康社会决定因素(SDH)方面落后于其他发达国家。这可能部分是由于针对解决 SDH 的医疗保健支付实施后结果的研究不足。本文着眼于国际和国内使用的四种模型,概述了实施、成功、局限性以及支持 SDH 模型在全国范围内应用所需的研究。简要介绍了先前模型的历史,作为当前美国系统的入门知识。在国际上,英国和新西兰采用小区域指数根据一个地区社会需求的增加来调整医疗保健美元分配。尽管有基于 SDH 的不同健康结果的出版证据,但关于 SDH 指数、随后增加的报销和改善医疗保健公平性的研究有限。在美国,马萨诸塞州管理式医疗组织评估并解决 Medicaid 服务社区的社会需求。毫不奇怪,有证据表明健康结果较差的人与社会需求较高的人之间存在重叠。然而,马萨诸塞州的实施时间太短,无法证明医疗保健差距缩小。在明尼苏达州,亨内平县医疗系统根据部分人头付费报销计划启动了一项新的 Medicaid 豁免,为高需求患者提供扩展服务。这些服务包括增加获得初级保健的机会,在改善系统财务状况方面取得了有希望的成果,但尚未证明对患者有利的结果。全球范围内已经确定了高社会风险与不良医疗结果之间的关联;然而,旨在应对这种关系的医疗保健支付政策通常缺乏影响结果的证据。美国政策制定者越来越有兴趣要求在医疗保健中捕捉 SDH,为解决 SDH 承担责任,为具有较高社会风险的患者支付不同的费用,或者三者兼而有之。在具有调整医疗保健支付以应对社会风险传统的国家,对相关影响进行更有力的评估可能会有所帮助。承担类似资源承诺的支付者、州或卫生系统应建立对结果的强大纵向评估,以告知其支付政策的演变。补充资料:本文是由美国卫生与公众服务部医疗保健研究与质量局、Kaiser Permanente 和 Robert Wood Johnson 基金会赞助的题为“在临床环境中识别和干预社会需求:证据和证据差距”的补充材料的一部分。